Barclays Begins Coverage on Mettler-Toledo International (NYSE:MTD)

Stock analysts at Barclays began coverage on shares of Mettler-Toledo International (NYSE:MTD - Get Free Report) in a note issued to investors on Tuesday,Briefing.com Automated Import reports. The brokerage set an "overweight" rating and a $1,325.00 price target on the medical instruments supplier's stock. Barclays's target price suggests a potential upside of 13.78% from the stock's previous close.

MTD has been the topic of a number of other reports. Citigroup raised shares of Mettler-Toledo International from a "neutral" rating to a "buy" rating and set a $1,400.00 price target on the stock in a report on Monday, April 7th. UBS Group upgraded shares of Mettler-Toledo International from a "neutral" rating to a "buy" rating and lowered their target price for the stock from $1,530.00 to $1,350.00 in a research note on Tuesday, May 20th. Wells Fargo & Company boosted their price target on shares of Mettler-Toledo International from $1,125.00 to $1,200.00 and gave the stock an "equal weight" rating in a research note on Monday, May 5th. Robert W. Baird reduced their price objective on Mettler-Toledo International from $1,369.00 to $1,034.00 and set a "neutral" rating on the stock in a research note on Tuesday, April 22nd. Finally, Wall Street Zen lowered Mettler-Toledo International from a "buy" rating to a "hold" rating in a research report on Monday, May 5th. Seven investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company's stock. According to MarketBeat.com, Mettler-Toledo International has an average rating of "Hold" and an average price target of $1,304.40.

Mettler-Toledo International Stock Performance

NYSE:MTD opened at $1,164.53 on Tuesday. Mettler-Toledo International has a 52 week low of $946.69 and a 52 week high of $1,546.93. The firm has a 50-day moving average price of $1,120.21 and a two-hundred day moving average price of $1,199.56. The firm has a market cap of $24.20 billion, a price-to-earnings ratio of 29.04, a price-to-earnings-growth ratio of 3.42 and a beta of 1.38.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last announced its quarterly earnings data on Thursday, May 1st. The medical instruments supplier reported $8.19 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $7.90 by $0.29. The firm had revenue of $883.74 million during the quarter, compared to the consensus estimate of $876.61 million. Mettler-Toledo International had a negative return on equity of 556.22% and a net margin of 22.17%. The business's revenue for the quarter was down 4.6% on a year-over-year basis. During the same quarter in the prior year, the company earned $8.89 EPS. As a group, sell-side analysts forecast that Mettler-Toledo International will post 42.71 earnings per share for the current year.

Insider Activity

In related news, Director Michael A. Kelly sold 1,062 shares of the company's stock in a transaction that occurred on Wednesday, May 28th. The stock was sold at an average price of $1,159.93, for a total value of $1,231,845.66. Following the transaction, the director now directly owns 120 shares of the company's stock, valued at approximately $139,191.60. This represents a 89.85% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Corporate insiders own 0.77% of the company's stock.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the business. SBI Securities Co. Ltd. purchased a new position in shares of Mettler-Toledo International in the fourth quarter valued at about $33,000. WPG Advisers LLC purchased a new position in Mettler-Toledo International during the first quarter valued at $41,000. Zions Bancorporation National Association UT bought a new stake in Mettler-Toledo International in the 1st quarter valued at $43,000. Edmond DE Rothschild Holding S.A. purchased a new stake in Mettler-Toledo International in the 4th quarter worth $44,000. Finally, Golden State Wealth Management LLC boosted its holdings in shares of Mettler-Toledo International by 583.3% during the 1st quarter. Golden State Wealth Management LLC now owns 41 shares of the medical instruments supplier's stock valued at $48,000 after purchasing an additional 35 shares during the last quarter. Hedge funds and other institutional investors own 95.07% of the company's stock.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.